肿瘤靶向药物不良反应的药学服务关注点

随着分子生物学技术的发展，越来越多的靶向药物被成功研发并上市。靶向药物具有靶向性强、不良反应相对较低等优点，能够对肿瘤细胞内异常的信号通路靶点特异性杀伤，进而抑制肿瘤的发生发展。但靶向药物的不良反应仍是无法回避的问题。同时，该类药品往往价格昂贵，如何合理使用，使其发挥应有的作用是药师应关注的问题。本文详述了靶向药物的分类以及上市情况，总结了靶向药物常见的不良反应及防治，以期为靶向药物的药学监护提供客观依据。

Focus on pharmaceutical services for adverse reactions of tumor-targeted drugs

With the development of molecular biology technology, more and more targeted drugs have been successfully developed and marketed. Targeted drugs have the advantages of strong targeting capabilites and relatively lower adverse reactions, which can specifically kill the abnormal signal pathway targets in tumor cells, thereby inhibiting the occurrence and development of tumors. However, the adverse reactions of targeted drugs are still unavoidable. Meanwhile, targeted drugs are always expensive. So how to utilize them reasonably to make them play their due role is a issue that pharmacists should focus on.